0001231919-25-000548.txt : 20251125 0001231919-25-000548.hdr.sgml : 20251125 20251124195206 ACCESSION NUMBER: 0001231919-25-000548 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251125 DATE AS OF CHANGE: 20251124 EFFECTIVENESS DATE: 20251125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solve Therapeutics, Inc. CENTRAL INDEX KEY: 0001905252 ORGANIZATION NAME: EIN: 863795367 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-564959 FILM NUMBER: 251514714 BUSINESS ADDRESS: STREET 1: 1025 ALAMEDA DE LAS PULGAS, SUITE 122 CITY: BELMONT STATE: CA ZIP: 94002 BUSINESS PHONE: (858) 357-4137 MAIL ADDRESS: STREET 1: 1025 ALAMEDA DE LAS PULGAS, SUITE 122 CITY: BELMONT STATE: CA ZIP: 94002 D 1 primary_doc.xml X0708 D LIVE 0001905252 Solve Therapeutics, Inc. 1025 ALAMEDA DE LAS PULGAS, SUITE 122 BELMONT CA CALIFORNIA 94002 (858) 357-4137 DELAWARE None None Corporation true 2021 David Johnson c/o Solve Therapeutics, Inc. 1025 Alameda De Las Pulgas, Suite 122 Belmont CA CALIFORNIA 94002 Executive Officer Director Peter Colabuono c/o Solve Therapeutics, Inc. 1025 Alameda De Las Pulgas, Suite 122 Belmont CA CALIFORNIA 94002 Director Alan Colowick c/o Solve Therapeutics, Inc. 1025 Alameda De Las Pulgas, Suite 122 Belmont CA CALIFORNIA 94002 Director Langdon Miller c/o Solve Therapeutics, Inc. 1025 Alameda De Las Pulgas, Suite 122 Belmont CA CALIFORNIA 94002 Executive Officer Jason Pitts c/o Solve Therapeutics, Inc. 1025 Alameda De Las Pulgas, Suite 122 Belmont CA CALIFORNIA 94002 Director Clayton D. Knox c/o Solve Therapeutics, Inc. 1025 Alameda De Las Pulgas, Suite 122 Belmont CA CALIFORNIA 94002 Executive Officer Daniel McHugh c/o Solve Therapeutics, Inc. 1025 Alameda De Las Pulgas, Suite 122 Belmont CA CALIFORNIA 94002 Director Robert Mittendorff c/o Solve Therapeutics, Inc. 1025 Alameda De Las Pulgas, Suite 122 Belmont CA CALIFORNIA 94002 Director Biotechnology Decline to Disclose 06b false 2025-11-14 false true false 0 120535618 48214232 72321386 false 16 0 0 0 false Solve Therapeutics, Inc. /s/ David Johnson David Johnson Chief Executive Officer 2025-11-24